Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
Ying-Chou ChenWen-Chan ChiuFu-Mei SuJia-Feng ChenPublished in: International journal of rheumatic diseases (2017)
In a 6-month head-to-head comparison of patients with RA, tocilizumab and adalimumab had a greater effect on reducing synovial hypertrophy, while adalimumab had a greater effect in controlling inflammation in PD.
Keyphrases
- rheumatoid arthritis
- disease activity
- juvenile idiopathic arthritis
- high resolution
- ankylosing spondylitis
- interstitial lung disease
- rheumatoid arthritis patients
- oxidative stress
- magnetic resonance imaging
- emergency department
- optic nerve
- computed tomography
- systemic lupus erythematosus
- systemic sclerosis
- ultrasound guided
- hidradenitis suppurativa
- contrast enhanced ultrasound
- idiopathic pulmonary fibrosis